Clinical Trials Browser

Prostatic Neoplasms × lutetium Lu 177 dotatate × 30 days × Clear all

NCT05691465 2026-05-27

Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Cancer That Has Neuroendocrine Cells

Phase 2 Recruiting

Prostatic Neoplasms